Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance

Prevalence and risk factors of Helicobacter pylori infection in Korea: Nationwide multicenter study over 13 years

(2013) Seon Hee Lim et al.   BMC GASTROENTEROLOGY

Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials

(2013) Hui-Lin Tang et al.   PLoS One

Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection

(2012) A. G. McNicholl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole

(2010) Jeong Hoon Lee et al.   Gut and Liver

Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition

(2010) Masahiro Asaka et al.   HELICOBACTER

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE

Annual Change of Primary Resistance to Clarithromycin among Helicobacter pylori Isolates from 1996 through 2008 in Japan

(2009) Noriyuki Horiki et al.   HELICOBACTER

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Efficacy of Helicobacter pylori eradication therapy in chronic liver disease

(2008) S.W. Jung et al.   DIGESTIVE AND LIVER DISEASE

Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis

(2008) Fujun Zhao et al.   HELICOBACTER

Effect of the CYP2C19 polymorphism on the eradication rate ofHelicobacter pyloriinfection by 7-day triple therapy with regular proton pump inhibitor dosage

(2008) Jung Mook Kang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY